Healthcare & Life Sciences
NeuExcell
United Stateswww.neuexcell.com/
NeuExcell is a series a startup based in United States. 1 investor tracked.
Activeseries-a
series-a
Stage
2017
Founded
1
Investors
About NeuExcell
Based in the United States, NeuExcell is a startup founded in 2017. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
NeuExcell is a gene therapy company focused on developing neuro-regenerative therapies for neurodegenerative diseases, including Huntington's Disease, Parkinson's Disease, and stroke.
Explore NeuExcell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.